Treating tough tumors by exploiting their iron 'addiction'
Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account ...
Mar 9, 2022
0
5